| dc.contributor.author | Russell Pj | en_US |
| dc.contributor.author | Martiniello-Wilks Rosetta | en_US |
| dc.contributor.author | Lockett Lj | en_US |
| dc.contributor.author | Brookes Diana | en_US |
| dc.contributor.author | Zandvliet D | en_US |
| dc.contributor.author | Watt F | en_US |
| dc.contributor.author | Molloy Pl | en_US |
| dc.contributor.author | Khatri A | en_US |
| dc.contributor.author | Both Gw | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2012-02-02T10:57:59Z | |
| dc.date.available | 2012-02-02T10:57:59Z | |
| dc.date.issued | 1998 | en_US |
| dc.identifier | 2010000590 | en_US |
| dc.identifier.citation | Russell Pj et al. 1998, 'Prostate cancer gene therapy', Australian Biotechnology Assoc Ltd, vol. 8, no. 2, pp. 99-106. | en_US |
| dc.identifier.issn | 1036-7128 | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/15475 | |
| dc.description.abstract | Recent developments in molecular biology have provided the opportunity for new gene therapy-based approaches for treating prostate cancer. A range of approaches are being taken for different cancer types, with over a hundred clinical trials of gene thera | en_US |
| dc.language | en_US | |
| dc.publisher | Australian Biotechnology Assoc Ltd | en_US |
| dc.relation.isbasedon | NA | en_US |
| dc.title | Prostate cancer gene therapy | en_US |
| dc.parent | Australasian Biotechnology | en_US |
| dc.journal.volume | 8 | en_US |
| dc.journal.number | 2 | en_US |
| dc.publocation | Gardenvale, Australia | en_US |
| dc.identifier.startpage | 99 | en_US |
| dc.identifier.endpage | 106 | en_US |
| dc.cauo.name | SCI.Medical and Molecular Biosciences | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 100400 | en_US |
| dc.personcode | 0000065249;106503;0000065275;0000050603;0000065274;0000065278;0000065266;0000065247;0000065258 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Medical Biotechnology | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | ISI:000074256900021 | en_US |
| dc.description.keywords | In-Vivo; Membrane Antigen; Adenovirus; Cells; Interleukin-2; Expression; Model | en_US |
| dc.staffid | en_US |